Department of Vasculitis, University of Oregon, 1585 E 13 Ave, Eugene, OR 97403, USA
Mini Review
Exploring New Therapeutic Targets for the Treatment of Large Vessel Vasculitis
Author(s): Melissa Sharon*
Large Vessel Vasculitis (LVV) encompasses a group of inflammatory disorders primarily affecting the aorta and its major branches, including
Giant Cell Arteritis (GCA) and Takayasu Arteritis (TA). Despite advancements in treatment, management of LVV remains challenging due to
relapses, glucocorticoid dependency, and treatment-related adverse effects. This article explores novel therapeutic targets and emerging treatment
strategies for LVV, including immunomodulatory agents, targeted biologic therapies, and small molecule inhibitors. By elucidating the underlying
pathophysiological mechanisms and investigating innovative treatment approaches, healthcare providers can optimize outcomes and improve
quality of life for patients with LVV... Read More»
DOI:
10.37421/2471-9544.2024.10.223
Journal of Vasculitis received 83 citations as per Google Scholar report